EXMceuticals Inc. (EXM) is a Canadian publicly-traded company (CSE: EXM | FSE: A2PAW2) with Operations in Portugal. EXM is a biotech company focused on cannabinoid extraction, purification and formulation for medical purposes. We have an operating-licensed cannabis R&D facility and pilot refinery in Lisbon, Portugal. We target the B2B marketplace and will supply pure ingredients to the pharmaceutical, medicinal and wellness industry.
| Website | https://exmceuticals.com/investors/ |
| Revenue | $8 million |
| Funding | $1 million |
| Employees | 6 (4 on RocketReach) |
| Founded | 2017 |
| Address | 140 Buckingham Palace Road, London, Greater London SW1W 9SA, GB |
| Industry | Wholesale, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Keywords | Cannabinoid Extraction, Medical Cannabis, Cannabis Extracts, Pharmaceutical, Drug Development, Pharmaceutical Research, Biotech, Cannabis Science, Plant Based Medicine, Biotechnology, Drug Manufacturing, Natural Medicine, Plant Based Remedies, Alternative Medicine, Health And Wellness, Wellness Products, Herbal Remedies |
| Competitors | Canopy Growth Corporation, Tilray Brands, Inc., Cronos Group, Aphria, Hexo, Organigram Inc, Charlotte's Web, MedMen, Trulieve, Curaleaf +32 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular EXMceuticals employee's phone or email?
EXMceuticals Questions
The EXMceuticals annual revenue was $8 million in 2026.
Marc Bernier is the Chief Strategy Officer of EXMceuticals.
4 people are employed at EXMceuticals.
EXMceuticals is based in London, Greater London.
The NAICS codes for EXMceuticals are [325, 32, 3254, 32541].
The SIC codes for EXMceuticals are [283, 28].
Top EXMceuticals Employees
Related Companies
